BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34621797)

  • 1. Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio With Diabetic Retinopathy.
    Tang X; Tan Y; Yang Y; Li M; He X; Lu Y; Shi G; Zhu Y; Nie Y; Li H; Mu P; Chen Y
    Front Cardiovasc Med; 2021; 8():707008. PubMed ID: 34621797
    [No Abstract]   [Full Text] [Related]  

  • 2. The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes.
    Chen JW; Li C; Liu ZH; Shen Y; Ding FH; Shu XY; Zhang RY; Shen WF; Lu L; Wang XQ
    Front Endocrinol (Lausanne); 2019; 10():191. PubMed ID: 31019490
    [No Abstract]   [Full Text] [Related]  

  • 3. Monocyte to High-Density Lipoprotein Cholesterol Ratio at the Nexus of Type 2 Diabetes Mellitus Patients With Metabolic-Associated Fatty Liver Disease.
    Jia J; Liu R; Wei W; Yu F; Yu X; Shen Y; Chen C; Cai Z; Wang C; Zhao Z; Wang D; Yang L; Yuan G
    Front Physiol; 2021; 12():762242. PubMed ID: 34975521
    [No Abstract]   [Full Text] [Related]  

  • 4. Monocyte to high-density lipoprotein cholesterol ratio in patients with diabetes mellitus and diabetic nephropathy.
    Karatas A; Turkmen E; Erdem E; Dugeroglu H; Kaya Y
    Biomark Med; 2018 Sep; 12(9):953-959. PubMed ID: 30043636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of Monocyte/High-Density Lipoprotein Cholesterol Ratio with Coronary Artery Disease in Type 2 Diabetes Mellitus.
    Ya G; Qiu Z; Tianrong P
    Clin Lab; 2018 Jun; 64(6):901-906. PubMed ID: 29945315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-to-high-density lipoprotein cholesterol ratio and the risk of erectile dysfunction: a study from NHANES 2001-2004.
    Wu X; Zhang Y; Jiang H; Zhang X
    Sex Med; 2024 Apr; 12(2):qfae025. PubMed ID: 38715577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte to High-Density lipoprotein and Apolipoprotein A1 Ratios: Novel Indicators for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes.
    Wang W; Chen ZY; Guo XL; Tu M
    Front Endocrinol (Lausanne); 2022; 13():935776. PubMed ID: 35909551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of monocyte-to-high density lipoprotein-cholesterol ratio with peripheral neuropathy in patients with Type II diabetes mellitus.
    Gökçay Canpolat A; Emral R; Keskin Ç; Canlar Ş; Şahin M; Çorapçioğlu D
    Biomark Med; 2019 Aug; 13(11):907-915. PubMed ID: 31321988
    [No Abstract]   [Full Text] [Related]  

  • 9. The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome.
    Li C; Fan H; Liu Y; Zeng L; Chen P; Duan C; Liang H; He P
    Ann Transl Med; 2021 Nov; 9(21):1627. PubMed ID: 34926671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte/High-Density Lipoprotein Cholesterol Ratio Predicts Vitamin D Deficiency in Male Patients with Type 2 Diabetes Mellitus.
    Zhao X; Deng C; Li Z; Jia Y; Chen S
    Diabetes Metab Syndr Obes; 2022; 15():2455-2466. PubMed ID: 35982762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: A cross-sectional study.
    Song Y; Zhao Y; Shu Y; Zhang L; Cheng W; Wang L; Shu M; Xue B; Wang R; Feng Z; Yin Y; Yu F; Jin S
    Front Endocrinol (Lausanne); 2023; 14():1100453. PubMed ID: 36875480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between monocyte to high-density lipoprotein cholesterol ratio and chronic kidney disease in a Chinese adult population: a cross-sectional study.
    Xu L; Li D; Song Z; Liu J; Zhou Y; Yang J; Wen P
    Ren Fail; 2024 Dec; 46(1):2331614. PubMed ID: 38522954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the performance of monocyte to high-density lipoprotein ratio for predicting ischemic stroke: insights from a population-based Chinese cohort.
    Wang HY; Shi WR; Yi X; Zhou YP; Wang ZQ; Sun YX
    Lipids Health Dis; 2019 May; 18(1):127. PubMed ID: 31142338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study.
    Zhang C; Lin W; Xu Q; Li H; Xu C; Ma X; Hao M; Kuang H
    J Diabetes Complications; 2023 Jun; 37(6):108471. PubMed ID: 37127002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy.
    Onalan E
    Pak J Med Sci; 2019; 35(4):1081-1086. PubMed ID: 31372147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of monocyte to high-density lipoprotein ratio on prevalent hyperuricemia: findings from a rural Chinese population.
    Chen MQ; Shi WR; Shi CN; Zhou YP; Sun YX
    Lipids Health Dis; 2020 Mar; 19(1):48. PubMed ID: 32178680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.
    Rema M; Srivastava BK; Anitha B; Deepa R; Mohan V
    Diabet Med; 2006 Sep; 23(9):1029-36. PubMed ID: 16922712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Monocyte-to-HDL Cholesterol Ratio with Endothelial Dysfunction in Patients with Type 2 Diabetes.
    Zhang H; Lu J; Gao J; Sha W; Cai X; Rouzi MRYM; Xu Y; Tang W; Lei T
    J Diabetes Res; 2024; 2024():5287580. PubMed ID: 38239233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation Between Glycolipid Metabolism Levels and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus.
    Wang S; Pan X; Zhang M; Chen S
    Diabetes Metab Syndr Obes; 2024; 17():1-9. PubMed ID: 38192497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of empagliflozin use on monocyte high-density lipoprotein ratio and plasma atherogenic index in obese and non-obese type 2 diabetic patients.
    Sivgin H; Çetin S
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):8090-8100. PubMed ID: 37750637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.